Online citations, reference lists, and bibliographies.

The Role Of Antimicrobial Peptides In Preventing Multidrug-Resistant Bacterial Infections And Biofilm Formation

S. Park, Y. Park, Kyung-soo Hahm
Published 2011 · Biology, Medicine
Cite This
Download PDF
Analyze on Scholarcy
Share
Over the last decade, decreasing effectiveness of conventional antimicrobial-drugs has caused serious problems due to the rapid emergence of multidrug-resistant pathogens. Furthermore, biofilms, which are microbial communities that cause serious chronic infections and dental plaque, form environments that enhance antimicrobial resistance. As a result, there is a continuous search to overcome or control such problems, which has resulted in antimicrobial peptides being considered as an alternative to conventional drugs. Antimicrobial peptides are ancient host defense effector molecules in living organisms. These peptides have been identified in diverse organisms and synthetically developed by using peptidomimic techniques. This review was conducted to demonstrate the mode of action by which antimicrobial peptides combat multidrug-resistant bacteria and prevent biofilm formation and to introduce clinical uses of these compounds for chronic disease, medical devices, and oral health. In addition, combinations of antimicrobial peptides and conventional drugs were considered due to their synergetic effects and low cost for therapeutic treatment.
This paper references
10.1038/nrmicro1098
Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria?
K. Brogden (2005)
10.1016/j.coph.2008.06.002
Discovering and improving novel peptide therapeutics.
D. P. McGregor (2008)
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license
10.1177/09680519050110030501
Lipid-mediated resistance of Gram-negative bacteria against various pore-forming antimicrobial peptides
Thomas Gutsmann (2005)
10.1016/S0092-8674(00)81750-X
Lipid A Acylation and Bacterial Resistance against Vertebrate Antimicrobial Peptides
Lin Guo (1998)
10.1086/338514
Inhibition of intracellular macromolecular synthesis in Staphylococcus aureus by thrombin-induced platelet microbicidal proteins.
Y. Xiong (2002)
10.5694/j.1326-5377.1957.tb57745.x
Protein Digestion and Absorption
D. Matthews (2006)
10.1016/j.peptides.2010.03.032
Cell selectivity and anti-inflammatory activity of a Leu/Lys-rich α-helical model antimicrobial peptide and its diastereomeric peptides
Peng Wang (2010)
10.1146/annurev.cellbio.21.012704.131001
Quorum sensing: cell-to-cell communication in bacteria.
C. Waters (2005)
10.1126/science.284.5418.1318
Bacterial biofilms: a common cause of persistent infections.
J. Costerton (1999)
10.1016/S0006-3495(01)75802-X
Barrel-stave model or toroidal model? A case study on melittin pores.
L. Yang (2001)
10.1016/j.bbamem.2008.10.009
Structure, membrane orientation, mechanism, and function of pexiganan--a highly potent antimicrobial peptide designed from magainin.
Lindsey M. Gottler (2009)
10.1016/j.bbrc.2010.04.073
Antimicrobial and antibiofilm activity of cathelicidins and short, synthetic peptides against Francisella.
Lilian S Amer (2010)
10.1016/0003-9861(84)90352-7
Binding of simple carbohydrates and some N-acetyllactosamine-containing oligosaccharides to Erythrina cristagalli agglutinin as followed with a fluorescent indicator ligand.
H. De Boeck (1984)
10.1128/AAC.01688-08
Inhibitory Effects of Lactoferrin on Growth and Biofilm Formation of Porphyromonas gingivalis and Prevotella intermedia
Hiroyuki Wakabayashi (2009)
10.1177/0022034509351812
Oral Biofilms: Emerging Concepts in Microbial Ecology
Sara K Filoche (2010)
Amphipathic alpha-helical peptide, HP (2-20), and its analogues derived from Int
S. C. Park (2011)
10.1099/00221287-147-1-3
Biofilm exopolysaccharides: a strong and sticky framework.
I. Sutherland (2001)
10.1039/b413734p
Antibiotic resistance: multidrug efflux proteins, a common transport mechanism?
Kate Langton (2005)
10.1016/j.addr.2009.02.010
PEG conjugates in clinical development or use as anticancer agents: an overview.
Gianfranco Pasut (2009)
10.1167/iovs.09-4068
In vivo performance of melimine as an antimicrobial coating for contact lenses in models of CLARE and CLPU.
Nerida Cole (2010)
10.1007/s00253-010-2468-8
Molecular mechanisms of compounds affecting bacterial biofilm formation and dispersal
Paolo Landini (2010)
10.1128/AEM.02073-07
Differential Roles of Poly-N-Acetylglucosamine Surface Polysaccharide and Extracellular DNA in Staphylococcus aureus and Staphylococcus epidermidis Biofilms
E. A. Izano (2007)
10.1177/08959374000140010401
Saliva and Dental Plaque
J. Rudney (2000)
10.2174/092986709787002619
Efflux mechanism, an attractive target to combat multidrug resistant Plasmodium falciparum and Pseudomonas aeruginosa.
Sandrine Alibert-Franco (2009)
10.1016/j.bpj.2009.04.039
Characterization of antibiotic peptide pores using cryo-EM and comparison to neutron scattering.
Mikyung Han (2009)
10.1529/biophysj.104.049817
Melittin-induced bilayer leakage depends on lipid material properties: evidence for toroidal pores.
D. Allende (2005)
10.1016/0002-9343(91)90345-X
Catheter-associated urinary tract infections: epidemiology, pathogenesis, and prevention.
W. Stamm (1991)
10.1111/j.1432-1033.1997.00545.x
The solution structure and activity of caerin 1.1, an antimicrobial peptide from the Australian green tree frog, Litoria splendida.
H. Wong (1997)
10.1002/j.1460-2075.1991.tb07969.x
The peptide antibiotic microcin B17 induces double-strand cleavage of DNA mediated by E. coli DNA gyrase.
J. L. Vizán (1991)
10.1111/j.1574-6968.1998.tb12896.x
Mechanism of antimicrobial action of indolicidin.
C. Subbalakshmi (1998)
10.1177/00912709922008506
Microbial biofilms: their development and significance for medical device-related infections.
M. Habash (1999)
10.1111/j.1365-2672.2008.03942.x
A novel cationic-peptide coating for the prevention of microbial colonization on contact lenses.
M. Willcox (2008)
10.1093/jb/mvn134
Modification of antimicrobial peptide with low molar mass poly(ethylene glycol).
G. Zhang (2008)
10.1016/j.mib.2006.02.004
Quorum sensing and DNA release in bacterial biofilms.
A. L. Spoering (2006)
10.1038/415389a
Antimicrobial peptides of multicellular organisms
M. Zasloff (2002)
10.1016/J.BBAMEM.2007.09.020
Amphipathic alpha-helical peptide, HP (2-20), and its analogues derived from Helicobacter pylori: pore formation mechanism in various lipid compositions.
S. Park (2008)
10.7164/antibiotics.45.839
Mersacidin, a new antibiotic from Bacillus. In vitro and in vivo antibacterial activity.
S. Chatterjee (1992)
10.1074/jbc.274.26.18503
Lipid A modifications characteristic of Salmonella typhimurium are induced by NH4VO3 in Escherichia coli K12. Detection of 4-amino-4-deoxy-L-arabinose, phosphoethanolamine and palmitate.
Z. Zhou (1999)
10.1177/039139880903200903
Therapeutic Potential of Biofilm-Dispersing Enzymes
Jeffrey B Kaplan (2009)
10.1111/j.1399-302X.2009.00537.x
The effect of lactoferrin on oral bacterial attachment.
S. Y. Arslan (2009)
10.1177/00034894061150S906
Bacterial Biofilms in Chronic Rhinosinusitis
James N. Palmer (2006)
10.1159/000225955
ClpX Contributes to Innate Defense Peptide Resistance and Virulence Phenotypes of Bacillus anthracis
Shauna M. McGillivray (2009)
10.1128/AAC.27.5.836
Structural similarities of the staphylococcin-like peptide Pep-5 to the peptide antibiotic nisin.
Hans Georg Prof. Sahl (1985)
10.1016/j.tim.2005.05.011
Modulation of lung epithelial functions by Pseudomonas aeruginosa.
G. Lau (2005)
10.1128/iai.64.12.4922-4927.1996
Antiendotoxin activity of cationic peptide antimicrobial agents.
M. Gough (1996)
MBI-226. Micrologix/Fujisawa.
R. Isaacson (2003)
10.1093/jac/dkp346
Effects of daptomycin in combination with other antimicrobial agents: a review of in vitro and animal model studies.
Judith N. Steenbergen (2009)
10.1002/j.1875-9114.1992.tb04478.x
Bacterial resistance to beta-lactams, and its prevention with combination antimicrobial therapy.
Steven L. Barriere (1992)
10.1371/journal.pbio.0050307
Looking for Chinks in the Armor of Bacterial Biofilms
Don Monroe (2007)
10.7164/antibiotics.45.832
Mersacidin, a new antibiotic from Bacillus. Fermentation, isolation, purification and chemical characterization.
S. Chatterjee (1992)
10.2174/138920109787048616
Lantibiotics: mode of action, biosynthesis and bioengineering.
G. Bierbaum (2009)
10.1128/AAC.00836-07
Molecular Mechanism of Target Recognition by Subtilin, a Class I Lanthionine Antibiotic
Judicaël Parisot (2007)
10.1016/j.imbio.2007.11.008
Lipopolysaccharide sensing an important factor in the innate immune response to Gram-negative bacterial infections: benefits and hazards of LPS hypersensitivity.
Marina A. Freudenberg (2008)
Biological properties of structurally related alpha-helical cationic antimicrobial peptides.
Monisha Gough Scott (1999)
10.1111/j.1747-0285.2010.00973.x
Antimicrobial activity of short, synthetic cationic lipopeptides.
Garry Laverty (2010)
10.1007/BF01569817
Biofilms in device-related infections
N. Khardori (2005)
10.1016/j.bbamem.2010.01.014
The membrane insertion of helical antimicrobial peptides from the N-terminus of Helicobacter pylori ribosomal protein L1.
T. Lee (2010)
Fermentation, isolation, purification and chemical characterization
S Chatterjee (1992)
10.1021/ja0260871
Mimicry of Host-Defense Peptides by Unnatural Oligomers: Antimicrobial β-Peptides
E. Porter (2002)
10.1016/S0924-8579(99)00018-7
Introduction to biofilm.
J. Costerton (1999)
10.1016/j.bbamem.2007.01.005
Action mechanism of tachyplesin I and effects of PEGylation.
Yuichi Imura (2007)
10.1016/S0140-6736(01)05321-1
Antibiotic resistance of bacteria in biofilms
P. Stewart (2001)
10.1038/nsmb830
The nisin–lipid II complex reveals a pyrophosphate cage that provides a blueprint for novel antibiotics
S. Hsu (2004)
10.1128/AAC.43.7.1542
Salt-Resistant Alpha-Helical Cationic Antimicrobial Peptides
C. Friedrich (1999)
Beta-lactam antibiotic resistance: a current structural perspective.
M. S. Wilke (2005)
10.1016/j.bbrc.2006.02.090
Investigation of toroidal pore and oligomerization by melittin using transmission electron microscopy.
S. Park (2006)
10.1021/jp8109622
Magainin 2-induced pore formation in the lipid membranes depends on its concentration in the membrane interface.
Yukihiro Tamba (2009)
10.1080/08927010903216572
Prevention of biofilm formation on titanium surfaces modified with conjugated molecules comprised of antimicrobial and titanium-binding peptides
Masao Yoshinari (2010)
10.1016/0196-9781(85)90346-8
A mass spectrometric assay for novel peptides: Application to Xenopus laevis skin secretions
Bradford W. Gibson (1985)
10.1111/j.1462-5822.2009.01323.x
Evolving concepts in biofilm infections.
Luanne Hall-Stoodley (2009)
10.1111/j.1399-302X.2009.00518.x
The immune response of oral epithelial cells induced by single-species and complex naturally formed biofilms.
Joerg Eberhard (2009)
10.1016/j.mib.2005.08.016
β-Lactam antibiotic resistance: a current structural perspective
M. S. Wilke (2005)
10.1128/IAI.00318-08
Human Host Defense Peptide LL-37 Prevents Bacterial Biofilm Formation
Joerg Overhage (2008)
10.1016/j.ijantimicag.2007.11.012
Activity of daptomycin on biofilms produced on a plastic support by Staphylococcus spp.
S. Roveta (2008)
10.1016/j.pupt.2007.12.001
Pseudomonas aeruginosa biofilm formation in the cystic fibrosis airway.
S. Moreau-Marquis (2008)
10.1093/nar/gki725
Structural and DNA-binding studies on the bovine antimicrobial peptide, indolicidin: evidence for multiple conformations involved in binding to membranes and DNA
Chun-Hua Hsu (2005)
10.1128/AAC.00750-06
Acyl-Substituted Dermaseptin S4 Derivatives with Improved Bactericidal Properties, Including on Oral Microflora
Y. Porat (2006)
10.1016/j.peptides.2009.09.020
Antimicrobial specificity and mechanism of action of disulfide-removed linear analogs of the plant-derived Cys-rich antimicrobial peptide Ib-AMP1
Peng Wang (2009)
10.1177/0895937409335627
Antimicrobial Peptides for Plaque Control
K. Leung (2009)
10.2165/00063030-200822050-00004
The Impact of PEGylation on Biological Therapies
Francesco Maria Veronese (2012)
10.1016/j.bbamem.2010.04.004
Antimicrobial peptides in toroidal and cylindrical pores.
Maja Lazar Mihajlovic (2010)
10.1093/cid/cir257
Guidelines for the prevention of intravascular catheter-related infections.
N. O'grady (2011)
10.1007/s12016-008-8079-9
P. aeruginosa Biofilms in CF Infection
V. E. Wagner (2008)
10.1586/14787210.5.5.811
Polymyxin B: similarities to and differences from colistin (polymyxin E)
A. Kwa (2007)
Tumor necrosis factor-alpha induces functionally active hyaluronan-adhesive CD44 by activating sialidase through p38 mitogen-activated protein kinase in lipopolysaccharide-stimulated human monocytic cells.
Katrina Gee (2003)
10.1177/0022034509346811
Bacterial Interactions in Dental Biofilm Development
Kenichi Hojo (2009)
10.1146/annurev.bi.42.070173.000515
Bacterial cell surface polysaccharides.
Luis Glaser (1973)
10.1007/s00018-009-0129-9
Gramicidin S and polymyxins: the revival of cationic cyclic peptide antibiotics
Tatsushi Mogi (2009)
10.1021/bi7019904
Antimicrobial peptides with stability toward tryptic degradation.
Johan Svenson (2008)
10.1111/j.1600-051X.2005.00790.x
Dental plaque: biological significance of a biofilm and community life-style.
P. Marsh (2005)
10.1038/nrmicro821
Bacterial biofilms: from the Natural environment to infectious diseases
L. Hall-Stoodley (2004)
10.1177/011542650301800195
Guidelines for the prevention of intravascular catheter-related infections: Centers for Disease Control and Prevention.
D. Kovacevich (2003)
10.1007/s00018-011-0710-x
Multifunctional cationic host defence peptides and their clinical applications
Amy T. Y. Yeung (2011)
10.1111/j.1432-1033.1986.tb09933.x
Epidermin: sequencing of a heterodetic tetracyclic 21-peptide amide antibiotic.
H. Allgaier (1986)
10.2174/1389201023378436
Bifunctional penicillin-binding proteins: focus on the glycosyltransferase domain and its specific inhibitor moenomycin.
Anne Marie Di Guilmi (2002)
10.1038/292246a0
Sequence and specificity of two antibacterial proteins involved in insect immunity
H. Steiner (1981)
10.1074/jbc.M302309200
Tumor Necrosis Factor-α Induces Functionally Active Hyaluronan-adhesive CD44 by Activating Sialidase through p38 Mitogen-activated Protein Kinase in Lipopolysaccharide-stimulated Human Monocytic Cells*
K. Gee (2003)
10.1128/AAC.46.7.2132-2136.2002
Potential Therapeutic Role of Cationic Peptides in Three Experimental Models of Septic Shock
A. Giacometti (2002)
10.1111/j.1432-1033.1995.0827g.x
Biosynthesis and biological activities of lantibiotics with unique post-translational modifications.
H. Sahl (1995)
10.1016/J.BBAMEM.2007.06.013
Action mechanism of PEGylated magainin 2 analogue peptide.
Yuichi Imura (2007)
10.1093/jac/44.3.389
Ability of azlocillin and tobramycin in combination to delay or prevent resistance development in Pseudomonas aeruginosa.
Y L Wu (1999)
10.1128/AAC.00072-07
Cloning, Nucleotide Sequencing, and Analysis of the AcrAB-TolC Efflux Pump of Enterobacter cloacae and Determination of Its Involvement in Antibiotic Resistance in a Clinical Isolate
A. Pérez (2007)
10.1016/j.ijantimicag.2009.05.003
Antimicrobial and antifungal activities of a novel cationic antimicrobial peptide, omiganan, in experimental skin colonisation models.
Evelina Rubinchik (2009)
10.1093/jac/dkn393
Protective effects of the combination of alpha-helical antimicrobial peptides and rifampicin in three rat models of Pseudomonas aeruginosa infection.
O. Cirioni (2008)
10.1016/0378-8741(88)90095-5
Magainins, a class of antimicrobial peptides from Xenopus skin: isolation, characterization of two active forms, and partial cDNA sequence of a precursor.
M. Zasloff (1987)
10.1016/j.tim.2004.11.009
Quorum sensing in streptococcal biofilm formation.
P. Suntharalingam (2005)
10.1007/s00726-010-0632-1
C-terminal amidation of PMAP-23: translocation to the inner membrane of Gram-negative bacteria
J. Kim (2010)
10.1016/j.ijantimicag.2009.10.010
In vitro efficacy of a synthetic all-d antimicrobial peptide against clinically isolated drug-resistant strains.
Yoonkyung Park (2010)
10.5301/IJAO.2009.2704
Therapeutic potential of biofilm-dispersing enzymes.
Jeffrey B Kaplan (2009)
10.1128/iai.61.7.2978-2984.1993
Mechanisms of action on Escherichia coli of cecropin P1 and PR-39, two antibacterial peptides from pig intestine.
H. G. Boman (1993)
10.1517/14656566.7.6.653
Antimicrobial peptides: therapeutic potential
L. Zhang (2006)
10.1093/jac/dkh387
Mersacidin eradicates methicillin-resistant Staphylococcus aureus (MRSA) in a mouse rhinitis model.
D. Kruszewska (2004)
10.1016/j.bbamem.2004.09.011
Antibacterial activity and pore-forming properties of ceratotoxins: a mechanism of action based on the barrel stave model.
Yannick Bessin (2004)
10.1006/jmbi.1996.0293
Structure and orientation of the mammalian antibacterial peptide cecropin P1 within phospholipid membranes.
Ehud Gazit (1996)
10.1128/AAC.49.8.3302-3310.2005
Systemic Antibacterial Activity of Novel Synthetic Cyclic Peptides
Véronique Dartois (2005)
Biofilms in CF Infection
V E Wagner (2008)
10.1086/513850
How intracellular bacteria survive: surface modifications that promote resistance to host innate immune responses.
R. Ernst (1999)
10.1007/BF01569822
Dental plaque as a biofilm
P. D. Marsh (2005)
10.1006/bbrc.1998.8159
Mechanism of action of the antimicrobial peptide buforin II: buforin II kills microorganisms by penetrating the cell membrane and inhibiting cellular functions.
C. Park (1998)
10.1007/s00216-006-0720-y
The effect of the chemical, biological, and physical environment on quorum sensing in structured microbial communities
A. Horswill (2007)
10.1021/bi0012843
Interaction between heat shock proteins and antimicrobial peptides.
L. Otvos (2000)
10.1038/nbt1267
Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies
R. Hancock (2006)
10.1016/S0196-9781(01)00498-3
From “carpet” mechanism to de-novo designed diastereomeric cell-selective antimicrobial peptides
Y. Shai (2001)
10.1159/000104801
Microbiota of Plaque Microcosm Biofilms: Effect of Three Times Daily Sucrose Pulses in Different Simulated Oral Environments
C. Sissons (2007)
Curr. Opin. Investig. Drugs
R E Isaacson (2003)
10.1093/jac/dki266
Surveillance and epidemiology of MRSA bacteraemia in the UK.
A. Johnson (2005)
10.1128/AAC.01231-09
Synergy with Rifampin and Kanamycin Enhances Potency, Kill Kinetics, and Selectivity of DeNovo-Designed Antimicrobial Peptides
Aparna Anantharaman (2010)
10.2741/1134
Mechanism of antibiotic efflux in Gram-negative bacteria.
Helen I Zgurskaya (2003)
10.2174/092986609788681841
Membrane permeabilization by multivalent anti-microbial peptides.
Roland J. Pieters (2009)
10.1016/0306-3623(95)02141-8
Hypothermia as an indicator of the acute effects of lipopolysaccharides: comparison with serum levels of IL1β, IL6 and TNFα
R. Blanqué (1996)
10.7164/antibiotics.43.1403
Duramycins B and C, two new lanthionine containing antibiotics as inhibitors of phospholipase A2. Structural revision of duramycin and cinnamycin.
A. Fredenhagen (1990)
10.1111/j.1472-765X.2009.02778.x
Human cathelicidin peptide LL37 inhibits both attachment capability and biofilm formation of Staphylococcus epidermidis.
E. Hell (2010)
10.1021/bi0273563
Mechanism of lipid bilayer disruption by the human antimicrobial peptide, LL-37.
Katherine A Henzler Wildman (2003)
10.1016/j.bbapap.2005.10.019
Synergism of Leu-Lys rich antimicrobial peptides and chloramphenicol against bacterial cells.
Y. Park (2006)
10.1007/s00203-002-0436-0
Factors influencing methicillin resistance in staphylococci
B. Berger-Bächi (2002)
10.1128/AAC.42.1.154
The Lantibiotic Mersacidin Inhibits Peptidoglycan Synthesis by Targeting Lipid II
H. Brötz (1998)
10.1021/bi6025159
High-resolution solution structure of a designed peptide bound to lipopolysaccharide: transferred nuclear Overhauser effects, micelle selectivity, and anti-endotoxic activity.
S. Bhattacharjya (2007)
Mode of action of linear amphipathic alpha-helical antimicrobial peptides.
Z. Oren (1998)
10.1002/(SICI)1097-0282(1998)47:6<451::AID-BIP4>3.0.CO;2-F
Mode of action of linear amphipathic α‐helical antimicrobial peptides
Z. Oren (1998)
10.4161/viru.2.5.16140
Bacterial interactions in dental biofilm
Ruijie Huang (2011)
Biofilms in CF Infection. Clin. Rev. Allergy Immunol
V E Wagner (2008)
10.1111/j.1742-4658.2009.07359.x
Multifunctional host defense peptides: intracellular-targeting antimicrobial peptides.
Pierre Nicolas (2009)
10.1007/s00109-006-0143-4
Multifunctional antimicrobial peptides: therapeutic targets in several human diseases
Mohamed Zaiou (2006)
10.1007/s10534-010-9304-6
Periodontitis, periodontopathic bacteria and lactoferrin
Hiroyuki Wakabayashi (2010)
10.1073/pnas.0708254105
Peptoids that mimic the structure, function, and mechanism of helical antimicrobial peptides
Nathaniel P. Chongsiriwatana (2008)
10.1016/S0140-6736(47)90004-4
Further observations on an inhibitory substance (nisin) from lactic streptococci.
A. Mattick (1947)
Mimicry of host-defense peptides by unnatural oligomers: antimicrobial beta-peptides.
E. Porter (2002)
10.1093/jac/33.suppl_A.31
Bacterial biofilms: influence on the pathogenesis, diagnosis and treatment of urinary tract infections.
J. Nickel (1994)
10.1111/j.1699-0463.1997.tb00568.x
Mechanisms of methicillin resistance in staphylococci.
Odd Gunnar Brakstad (1997)
10.1016/j.bbamem.2009.02.020
Cell specificity, anti-inflammatory activity, and plausible bactericidal mechanism of designed Trp-rich model antimicrobial peptides.
K. H. Park (2009)
10.1146/annurev.bi.46.070177.003451
Polymyxin and related peptide antibiotics.
D. Storm (1977)
10.1021/JA075373F
Antimicrobial activity and protease stability of peptides containing fluorinated amino acids.
H. Meng (2007)
10.1146/annurev.mi.35.100181.001503
The bacterial glycocalyx in nature and disease.
J. Costerton (1981)
10.1128/AAC.01488-05
Proteolytic Degradation of Human Antimicrobial Peptide LL-37 by Bacillus anthracis May Contribute to Virulence
J. Thwaite (2006)
10.1038/nature03912
Aminoglycoside antibiotics induce bacterial biofilm formation
L. Hoffman (2005)
10.1021/bi011549t
Conjugation of a magainin analogue with lipophilic acids controls hydrophobicity, solution assembly, and cell selectivity.
D. Avrahami (2002)
10.1016/j.peptides.2005.10.007
Citropin 1.1-treated central venous catheters improve the efficacy of hydrophobic antibiotics in the treatment of experimental staphylococcal catheter-related infection
O. Cirioni (2006)
10.1177/003335490712200205
Estimating Health Care-Associated Infections and Deaths in U.S. Hospitals, 2002
R. Klevens (2007)
10.1086/502007
Guidelines for the prevention of intravascular catheter-related infections.
N. O'grady (2002)
10.1016/j.bbrc.2010.07.118
Antibiotic and synergistic effect of Leu-Lys rich peptide against antibiotic resistant microorganisms isolated from patients with cholelithiasis.
Nari Jeong (2010)
10.1099/mic.0
In vitro susceptibility of Staphylococcus aureus to thrombin-induced platelet microbicidal protein-1 (tPMP-1) is influenced by cell membrane phospholipid composition and asymmetry.
Kasturi Mukhopadhyay (2007)
10.1016/j.bbamem.2008.10.025
Buforins: histone H2A-derived antimicrobial peptides from toad stomach.
Ju Hyun Cho (2009)
10.1046/j.1432-1033.2002.03119.x
Identification of crucial residues for the antibacterial activity of the proline-rich peptide, pyrrhocoricin.
G. Kragol (2002)
10.1126/science.1129818
An Alternative Bactericidal Mechanism of Action for Lantibiotic Peptides That Target Lipid II
H. Hasper (2006)
10.1021/bi035643g
Structure-based design of an indolicidin peptide analogue with increased protease stability.
Annett Rozek (2003)
10.1128/AAC.01576-06
Efficacy of Tachyplesin III, Colistin, and Imipenem against a Multiresistant Pseudomonas aeruginosa Strain
O. Cirioni (2007)
10.1111/J.1601-0825.2007.01410B.X
Oral biofilms, periodontitis and pulmonary infections.
J. Brown (2007)
10.1038/nbt1309
Improved antimicrobial peptides based on acyl-lysine oligomers
I. Radzishevsky (2007)
10.1136/ard.62.suppl_2.ii17
Roles of antimicrobial peptides such as defensins in innate and adaptive immunity
J. Oppenheim (2003)
10.1016/j.bbamem.2009.08.012
Cholesterol reduces pardaxin's dynamics-a barrel-stave mechanism of membrane disruption investigated by solid-state NMR.
A. Ramamoorthy (2010)
10.1016/j.molcel.2011.04.003
A strategy for antagonizing quorum sensing.
Guozhou Chen (2011)
aeruginosa Biofilms in CF Infection
V. E. Iglewski Wagner (2008)
10.1016/0140-6736(93)91440-W
Vancomycin-resistant enterococci
A. Uttley (1993)
10.3201/eid1312.070629
Hospitalizations and Deaths Caused by Methicillin-Resistant Staphylococcus aureus, United States, 1999–2005
E. Klein (2007)
10.1007/s00018-008-7456-0
The Sushi peptides: structural characterization and mode of action against Gram-negative bacteria
J. Ding (2008)
10.1080/10408399409527650
Nisin as a model food preservative.
J. N. Hansen (1994)
10.1128/.67.4.2005-2009.1999
Biological Properties of Structurally Related α-Helical Cationic Antimicrobial Peptides
M. G. Scott (1999)
10.1124/pr.55.1.2
Mechanisms of Antimicrobial Peptide Action and Resistance
M. Yeaman (2003)
10.1007/s10620-006-9589-z
Human Pancreatic Digestive Enzymes
D. Whitcomb (2006)
10.1016/j.bbrc.2004.06.113
Antibacterial synergism of novel antibiotic peptides with chloramphenicol.
Y. Park (2004)
Hypothermia as an indicator of the acute effects of lipopolysaccharides: comparison with serum levels of IL1 beta, IL6 and TNF alpha.
Roland Blanqué (1996)
10.1016/j.archoralbio.2008.11.007
In vitro antimicrobial effect of bacteriocin PsVP-10 in combination with chlorhexidine and triclosan against Streptococcus mutans and Streptococcus sobrinus strains.
O. Lobos (2009)
10.1093/jac/dkp158
Antimicrobial and antibiofilm efficacy of triclosan and DispersinB combination.
Rabih O. Darouiche (2009)
10.1016/S0014-5793(02)03651-7
Interaction of hagfish cathelicidin antimicrobial peptides with model lipid membranes.
G. Basañez (2002)
10.1002/biot.200900218
PEGylation of therapeutic proteins.
Simona Jevševar (2010)
10.1016/j.ijantimicag.2009.12.011
Antibiotic resistance of bacterial biofilms.
Niels Høiby (2010)
10.1021/bi002656a
The antibacterial peptide pyrrhocoricin inhibits the ATPase actions of DnaK and prevents chaperone-assisted protein folding.
G. Kragol (2001)
10.1016/j.diagmicrobio.2004.02.008
In vitro activity and killing effect of the synthetic hybrid cecropin A-melittin peptide CA(1-7)M(2-9)NH(2) on methicillin-resistant nosocomial isolates of Staphylococcus aureus and interactions with clinically used antibiotics.
A. Giacometti (2004)
10.1021/bi9620621
Membrane pores induced by magainin.
S. Ludtke (1996)
10.1074/jbc.M405606200
Perturbation of Lipopolysaccharide (LPS) Micelles by Sushi 3 (S3) Antimicrobial Peptide
P. Li (2004)
10.1016/j.bbamem.2006.04.006
Tryptophan- and arginine-rich antimicrobial peptides: structures and mechanisms of action.
D. I. Chan (2006)
10.1016/S0006-3495(02)75595-1
Size distribution of barrel-stave aggregates of membrane peptides: influence of the bilayer lateral pressure profile.
R. Cantor (2002)



This paper is referenced by
10.1111/2049-632X.12151
Treatment of microbial biofilms in the post-antibiotic era: prophylactic and therapeutic use of antimicrobial peptides and their design by bioinformatics tools.
Mariagrazia Di Luca (2014)
10.1016/J.ANTINF.2013.05.001
Les peptides antimicrobiens cationiques : vers un renforcement de l’arsenal thérapeutique anti-infectieux ?
Margot Schlusselhuber (2013)
10.1128/AAC.01872-17
Fluconazole-Resistant Candida auris Is Susceptible to Salivary Histatin 5 Killing and to Intrinsic Host Defenses
R. U. Pathirana (2017)
10.1016/j.jconrel.2015.12.003
Prevention of Staphylococcus aureus biomaterial-associated infections using a polymer-lipid coating containing the antimicrobial peptide OP-145.
Anna de Breij (2016)
10.1007/s11274-013-1575-y
Investigation of the antibacterial activity of a short cationic peptide against multidrug-resistant Klebsiella pneumoniae and Salmonella typhimurium strains and its cytotoxicity on eukaryotic cells
Mehrdad Moosazadeh Moghaddam (2014)
10.3390/biom7040080
Significance and Diagnostic Role of Antimicrobial Cathelicidins (LL-37) Peptides in Oral Health
Zohaib Khurshid (2017)
10.26717/BJSTR.2018.07.001536
The Antimicrobial Peptides: Ready for Clinical Trials?
Michael A. B. Naafs (2018)
10.1128/genomeA.00599-13
Draft Genome Sequence of Lactococcus lactis subsp. lactis Strain YF11
Yuhui Du (2013)
10.1002/9783527652853.CH2
Cationic Antimicrobial Peptides
D. A. Phoenix (2013)
10.1007/s12602-019-09539-4
Study on Antiviral Activity of Two Recombinant Antimicrobial Peptides Against Tobacco Mosaic Virus
Mohammad Ali Sabokkhiz (2019)
10.1097/WON.0b013e3182750161
Guideline for the management of wounds in patients with lower-extremity neuropathic disease: an executive summary.
Penny Ellen Crawford (2013)
10.1007/978-981-32-9574-2_7
Bioactive Compounds from Marine Sources
Saleena Mathew (2019)
10.1128/AAC.00060-17
Synthetic Cyclic Peptomers as Type III Secretion System Inhibitors
Hanh Lam (2017)
Antimicrobial Peptides and Their Analogs: Searching for New Potential Therapeutics
Krystyna Midura (2014)
10.4172/2472-1212.1000141
Ceragenins as Mimics of Endogenous Antimicrobial Peptides
Marjan M. Hashemi (2017)
10.1179/1973947812Y.0000000045
Antibiofilm agents and implant-related infections in orthopaedics: where are we?
Carlo Luca Romanò (2013)
10.3389/fmicb.2017.00628
Targeted Modification of a Novel Amphibian Antimicrobial Peptide from Phyllomedusa tarsius to Enhance Its Activity against MRSA and Microbial Biofilm
Yitian Gao (2017)
10.1007/s12038-018-9790-1
Antibacterial properties of human beta defensin-3 derivative: CHRG01
Ashish Arora (2018)
10.1007/82_2016_491
Anti-infectives in Drug Delivery-Overcoming the Gram-Negative Bacterial Cell Envelope.
Florian Graef (2016)
10.3390/pharmaceutics11100506
Influence of Short Cationic Lipopeptides with Fatty Acids of Different Chain Lengths on Bacterial Biofilms Formed on Polystyrene and Hydrogel Surfaces
Malgorzata Anna Paduszynska (2019)
10.2174/138945012803530251
Resolving biofilm infections: current therapy and drug discovery strategies.
Max V. Ranall (2012)
10.3929/ETHZ-A-010496295
Evolutionary parasitology and antimicrobial defenses in a trypanosome-insect system
Monika Marxer (2015)
10.1080/09168451.2019.1670045
Brevinin-GR23 from frog Hylarana guentheri with antimicrobial and antibiofilm activities against Staphylococcus aureus
Hengren Zhong (2019)
10.3390/pharmaceutics11110588
Advances in Lipid and Metal Nanoparticles for Antimicrobial Peptide Delivery
Marcin Makowski (2019)
10.1016/j.jgar.2019.11.012
Non-antibiotic Antimicrobial Agents to Combat Biofilm-forming Bacteria.
Yuxue Cao (2019)
10.4304/TPLS.3.11.2046-2051
A Relevance-theoretic Analysis of Conversational Silence
Yanyan Jia (2013)
10.3390/ph6081055
Characterization of Antimicrobial Peptides toward the Development of Novel Antibiotics
Wataru Aoki (2013)
10.1002/bip.22885
Molecular design and genetic optimization of antimicrobial peptides containing unnatural amino acids against antibiotic-resistant bacterial infections.
Yongkang He (2016)
10.1016/j.biomaterials.2017.05.011
Engineering a sprayable and elastic hydrogel adhesive with antimicrobial properties for wound healing.
Nasim Annabi (2017)
10.1038/s41598-018-19752-w
AmPEP: Sequence-based prediction of antimicrobial peptides using distribution patterns of amino acid properties and random forest
Pratiti Bhadra (2018)
10.1016/j.biotechadv.2018.11.013
Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and alternative therapeutic strategies.
Zheng Pang (2019)
10.1002/jbm.a.34555
Graft copolymer polyelectrolyte complexes for delivery of cationic antimicrobial peptides.
Krista L. Niece (2013)
See more
Semantic Scholar Logo Some data provided by SemanticScholar